Cite
HARVARD Citation
Park, A. et al. (2015). Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII). Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].